Carlyle Group’s HilleVax HLVX Stock Holding History

Carlyle Group’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,838,486	Closed	-$3.59M	–	19
2025 Q2	$3.59M	Hold	1,838,486	–	–	0.07%	10
2025 Q1	$2.65M	Hold	1,838,486	–	–	0.07%	15
2024 Q4	$3.82M	Hold	1,838,486	–	–	0.09%	13
2024 Q3	$3.24M	Hold	1,838,486	–	–	0.34%	17
2024 Q2	$26.4M	Hold	1,838,486	–	–	2.51%	8
2024 Q1	$30.5M	Hold	1,838,486	–	–	1.92%	9
2023 Q4	$29.5M	Hold	1,838,486	–	–	1.42%	9
2023 Q3	$24.7M	Hold	1,838,486	–	–	1.07%	10
2023 Q2	$31.5M	Hold	1,838,486	–	–	1.12%	10
2023 Q1	$30.1M	Buy	+1,838,486	New	+$29.4M	0.9%	9

Carlyle Group's HLVX Position: Q3 2025 in Review

Carlyle Group sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 1,838,486 shares — an estimated $3.59M sold.

Carlyle Group first reported a position in HLVX in Q1 2023 and held it in 10 quarters. The position peaked at $31.5M in Q2 2023. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Carlyle Group reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Carlyle Group sold 1,838,486 HilleVax shares in Q3 2025, an estimated $3.59M.
Carlyle Group first reported a position in HilleVax in Q1 2023 and held it in 10 quarters.
Carlyle Group's HilleVax position peaked at $31.5M in Q2 2023.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Carlyle Group's 13F filing for Q3 2025, filed 7 Nov 2025.